Oost NL invests in Tyromer Europe (Q1 2021)
Advising Oost NL on its investment in Tyromer Europe
EUR 18.5M Series B financing round of InteRNA Technologies (Q1 2021)
Advising Oost NL on its participation in this series B round alongside AurorA Science, Waterman Ventures and Aglaia Oncology Funds.
Lumana Invest, Oost NL and Demcon invest in Eurekite (Q1 2021)
Advising Oost NL (IFT) and Demcon on their participation in the € 4.2 million investment in Eurekite